The QinetiQ Group, based in Farnborough, is selling off its fuel and lubricants business for £500,000, reports insidermedia.com.
The Intertek Group is to take over the UK Fuel and Lubricants Testing Business (OALTB), which QinetiQ has sold in order to concentrate on their core services, including aerospace and security. Intertek is going to bring the fuel business into the pharmaceutical and chemical division of their operations.
This is the third recent acquisition by Intertek, who have also purchased Stoke based Food Analytical Laboratories Limited (FAL) and Rechere Developpement and Consulting (RDC), based in Brussels. Wolfhart Hauser, CEO of Intertek, has said the purchases “demonstrate Intertek’s progress in its strategy to add new expertise and capabilities across the supply chain.” He later commented that the firm is looking forward “to welcoming these companies and their management teams to Intertek.”
The North West Fund is run by venture capital firm SPARK Impact and supplies debt and equity funding to small and medium sized businesses in the North West of England. Alchemy Healthcare has developed a nasal device for administering treatments in order to avoid injections. The investment they will receive will be used to “complete various elements of tooling and a modest clinical trial,” said Ian Harrison, the firm’s founder. They also hope to receive the results soon and receive further investment.
Future Medical Technologies has developed a polymer to mimic cartilage that is used to help arthritis, improving patient care. The investment will be used to speed development of the product and gain further regulatory approval. Dr Yousef Taktak has called the investment a “great opportunity.”
At least three private equity firms are planning a bid for GSK non-prescription drugs, reports Reuters.
The products being bid for include over the counter painkillers and vitamin supplements. These sales are the product of GSK’s reduction of non-core products announced in February, representing 10% of the consumer healthcare business. Bids for the products are expected on 8th August, but will be negotiable. CEO Andrew Witty expects the deals to close in the fourth quarter of 2011 before adding that GSK will be looking for the best deal for shareholders to benefit.
Rival companies are unlikely to bid for all the products GSK is looking to offload, worth a maximum of around £2 billion. However because the products will not be sold as a single body, analysts believe that GSK will not be able to make that amount. The lack of coherence in the products on sale, other than, as one analyst says “stuff that GSK doesn’t want,” also means it will be difficult to sell the portfolio for such an amount in one go.
Julie Marshall is currently recruiting for a Cell Biologist to join a Biopharma Unit in Cambridge on a temporary basis.
Responsibilities:
As a Cell Biologist you will assist with characterisation of the binding properties and biological activity of domain antibodies and recombinant proteins to support early stage drug discovery programmes.
The ideal candidate:
The ideal candidate for this Cell Biologist role will have the following skills:
Essential for this role is your practical experience in cell culture, assay development and optimisation of fluorescence based techniques such as Flow Cytometry, confocal microscopy and FRET.
Ability to implement and run siRNA knockdown protocols is essential.
You should be highly motivated and have a proven ability to handle multiple projects working both within a team and independently.
Your experience of biological assay techniques will be complemented with a desire to develop, trouble shoot and validate protocols.
Qualifications:
For this Cell Biologist role you must have a life science degree, PhD (or equivalent) and research experience in the field of cell biology and an understanding of molecular biology would be advantageous. This is a temporary position until December 2011.
How to apply:
For more information for or to apply for this Cell Biologist role please contact Julie Marshall on jmarshall@ckscience.co.uk. Please quote reference ST22426 in all correspondence.
Environmental chemists are much needed in most jobs, particularly in the pharmaceutical industry, reports ibnlive.com.
All industries need environmental officers to assess the effect the business has on the environment, and find ways to reduce that impact. The job essentially involves knowing the effects of chemicals (or whatever the business deals with) on the environment. For example, how can a pharmaceutical firm safely and effectively dispose of waste products or leftover stock?
Industries are taking a much more proactive role in environmental issues, so that the role of chemists is becoming prominent. Pharmaceutical, chemical and waste disposal industries all obviously need environmental chemists, but recently even IT firms are beginning to employ people to monitor their environmental impact. A solid grounding in chemistry is of great importance, and it is often recommended that those looking into such a role go on environmental courses.
Carrie Ann Bell is one of the recent additions to the ever expanding CK Science team and is based in our Durham office. Carrie Ann specialises in recruitment for the Pharmaceutical, Biotechnology, Medical Devices and Diagnostics industries.
Find out more about Carrie Ann by watching this short video:
Our client is a biotechnology company based in the North East of England. They require a manager to run their QC function.
Aswell as being technically competent, you must be able to work well under pressure, be able to deal with customers, colleagues and heads of other departments, and train and develop staff. You must be qualified to minimum HNC level in Microbiology or a related subject or possess equivalent industrial experience, and have a proven track record within a lab based supervisory role.
Apply Now
For more information, or to apply for this Laboratory Manager position, please contact Barney Smith on 0191 384 8905 or email bsmith@ckscience.co.uk. Please quote reference DH20844 in all correspondence.
A new multi-million pound state-of-the-art biotechnology facility for the global biopharma companyPfizer was opened by the Science Minister, David Willets today.
The new facility is based at the pharmaceutical company’s Havant site and has cost £26.3 million. This is a significant investment by Pfizer and is evidence to the UK’s strengths in life sciences and the pool of highly skilled pharmaceutical workers we have to offer. In fact, in 2009/2010, the UK alone attracted 173 life sciences investment projects, generating nearly 8,500 jobs.
Science Minister, David Willets stated, “Pfizer’s commitment to the UK is a big win for our life science and manufacturing base. I’m hugely encouraged that even in these tough economic times the world’s largest research-based biopharmaceutical company has chosen the UK to make this significant investment.
“The Government is determined to ensure that the UK has one of the leading business environments in the world for the life sciences and remains a global force in this field.”
A Protein Scientist is required to join a biotechnology company based in Cambridge, UK.
As Protein Scientist you will play an important role in supporting the different activities around rapid expression and scale-up of IgG using in-house protein expression technologies.
The Successful candidate for this Protein Scientist position will have a Degree in Life Sciences, (or equivalent experience) or a PhD (or equivalent) in Life Sciences would be desirable.
The key technical skills and competencies required for this Protein Scientist role include extensive experience in protein expression from eukaryotic cells in industrial environment and practical laboratory-based experience in cell culture. It is required you have experience in molecular biology.
You will be enthusiastic, flexible and willing to learn, as well as proactive with a high level of attention to detail. This is a contract position for 4 months and is a great opportunity to gain experience of working within a modern company in the Cambridge region.
Apply Now
For more information, or to apply for this Protein Scientist job, please contact Julie Marshall at CK Science on 01438 723 500 or email jmarshall@ckscience.co.uk. Please quote reference ST20524 in all correspondence.
Our client, is a leading global biotechnology company based in the Cambridgeshire/Suffolk area, looking for a Senior Quality Assurance Officer to join their QA team.
As Senior QA Officer, you will be responsible for reviewing documentation in accordance to in-house specifications as well as cGMP. You will also provide QA advice for deviation investigation, root causing and change management. Part of the role will include internal auditing and supervision of less experienced staff.
To be successful for this Senior QA Officer role you will have a BSc in a scientific discipline (or equivalent). Previous experience with deviation investigation, batch release of API and dealing with customer complaints is essential. Experience in auditing or documentation review within a Quality Management System is also essential.
This is a fantastic opportunity to join a biopharmaceutical company within an easy commuting distance from Cambridge.
Apply Now
For more information, or to apply for this Senior QA Officer position, please contact Reena at CK Science on 01438 723 500 or email rdhana@ckscience.co.uk. Please quote reference ST20411 in all correspondence.
![iStock_000006963239Medium[1]](http://ckscience.co.uk/wp-content/uploads/2010/10/iStock_000006963239Medium11-150x150.jpg "iStock_000006963239Medium[1]")
